Asx vht

Patient Hub. Speed your workflow with customizable patient reporting and communications. View patient risk insights essential for early detection. Risk Pathways.

Looks you are already a member. Please enter your password to proceed. Forgotten password? Click here. Please make sure your payment details are up to date to continue your membership.

Asx vht

December 14, James Mickleboro. November 28, Tristan Harrison. November 27, Tristan Harrison. November 22, Tristan Harrison. October 17, James Mickleboro. This health technology share is catching the eye with a very strong gain on Tuesday. September 27, Tristan Harrison. September 14, Tristan Harrison. September 5, Tristan Harrison. These companies are seeing pleasing demand for their technology offerings. July 26, Tristan Harrison. July 24, Tristan Harrison. July 19, Tristan Harrison. An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Volpara Health Technologies Ltd ASX: VHT is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

Earnings have grown 3. Is VHT overvalued? Prices are delayed by at least 20 minutes.

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board.

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. VHT chart. Today 0. Key stats. Market capitalization.

Asx vht

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance. Media centre. ASX rulebooks. ASX Compliance. ASX regulatory framework.

Go ibibo air

Last name is required. Holding Name 37,, The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. Not far now. Please make sure your payment details are up to date to continue your membership. An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. See Fair Value and valuation analysis. Chief Executive Officer Managing Director. Join Intelligent Investor today. No longer forecast to breakeven Apr Get fast imaging feedback for on-the job training. Looking for more…. ASX rulebooks.

Key events shows relevant news articles on days with large price movements.

Investment options. Log in. Clinical decision support. Feb Conversion of securities. You might already have an ASX account with another platform. These documents can be accessed on the Rask Invest website. Issuer Services. Refresh Data. ASX Compliance. John Pavlidis joined the VHT board in February and has more than 30 years of experience as a senior healthcare executive, CEO, or company director in the areas of womens health, diagnostic imaging, image analysis and artificial intelligence, and cardiovascular therapies. As one of the earliest healthcare technology lawyers in the USA, Karin has an in-depth knowledge of data governance, data privacy, SaaS, and US healthcare, and has extensive professional networks across the IT landscape. Start investing. Forecast breakeven date moved forward to Oct